Status:
RECRUITING
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
Lead Sponsor:
The Lymphoma Academic Research Organisation
Collaborating Sponsors:
Gilead Sciences
Novartis
Conditions:
Hematopathology Eligible or CAR-t Cell Treatment
Eligibility:
All Genders
Up to 99 years
Brief Summary
This study is a registry including prospective and retrospective data on all patients who have been presented in a Multidisciplinary tumor board or RCP to be eligible for CAR-T cell treatment.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Retrospective inclusion :
- Patient treated with CAR-T from 1 July 2018 under temporary authorization (ATU) or covered by French health insurance system (under post-ATU or MA) in a qualified center before activation of this register in this center
- If the patient is alive, the patient has been informed of the collection and use of their data, and the patient has not opposed this use. If the patient has died, the patient did not opposed the use of their data while alive
- Prospective inclusion :
- Patient eligible for a treatment with CAR-T for an hematological malignancy which is covered by French health insurance (for ATUs / post-ATUs or MA), or as part of a clinical trial with the same indication, after the activation of this register in this center.
- Patient whose CAR-T indication has been validated during a multidisciplinary tumor board (RCP) of a qualified center, according to the ministerial order of 8 August 2019
- Patient deemed eligible for a treatment with CAR-T after a medical exam performed in a qualified center according to the ministerial order of 8 August 2019
- If the patient is alive, the patient has been informed of the collection and use of their data, and the patient has not opposed this use. If the patient has died, the patient did not opposed the use of their data while alive.
- Exclusion Criteria Patient not registered with the social security in France
Exclusion
Key Trial Info
Start Date :
December 19 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 19 2038
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04328298
Start Date
December 19 2019
End Date
December 19 2038
Last Update
January 27 2025
Active Locations (36)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU d'Amiens - Hôpital Sud
Amiens, France
2
CHU Angers
Angers, France
3
CHRU Besançon - Hôpital Minjoz
Besançon, France
4
CHU de Brest - Hôpital du Morvan
Brest, France